Examining the clinical utility of lacosamide: pooled analyses of three phase II/III clinical trials.

• Lacosamide is an antiepileptic drug (AED) approved for the adjunctive treatment of partial-onset seizures in adults. Completed phase II/III clinical trials of lacosamide provide a valuable opportunity to evaluate clinically relevant aspects of the resulting large patient pool.

Nyckelord

Acetamides

administration & dosage

pharmacokinetics

therapeutic use

Adult

Anticonvulsants

administration & dosage

pharmacokinetics

therapeutic use

Clinical Trials

Phase II as Topic

Clinical Trials

Phase III as Topic

Dose-Response Relationship

Drug

Double-Blind Method

Epilepsies

Partial

drug therapy

physiopathology

surgery

Female

Humans

Male

Models

Biological

Multicenter Studies as Topic

Randomized Controlled Trials as Topic

Time Factors

Treatment Outcome

Publikations- och innehållstyp

ref (ämneskategori)

art (ämneskategori)